Cargando…

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice

Amyloid-β (Aβ) deposition is one of the hallmarks of the amyloid hypothesis in Alzheimer’s disease (AD). Mouse models using APP-transgene overexpression to generate amyloid plaques have shown to model only certain parts of the disease. The extent to which the data from mice can be transferred to man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steffen, Johannes, Krohn, Markus, Schwitlick, Christina, Brüning, Thomas, Paarmann, Kristin, Pietrzik, Claus U., Biverstål, Henrik, Jansone, Baiba, Langer, Oliver, Pahnke, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480119/ https://www.ncbi.nlm.nih.gov/pubmed/28637503 http://dx.doi.org/10.1186/s40478-017-0448-2

Ejemplares similares

Neural compensation in presymptomatic hAPP mouse models of Alzheimer's disease
por: Ammassari-Teule, Martine
Publicado: (2020)

Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice
por: Lanooij, Suzanne D., et al.
Publicado: (2023)

Revisiting rodent models: Octodon degus as Alzheimer’s disease model?
por: Steffen, Johannes, et al.
Publicado: (2016)

Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
por: Wu, Zhourui, et al.
Publicado: (2020)

A New Tool for the Analysis of the Effect of Intracerebrally Injected Anti-Amyloid-β Compounds
por: Upīte, Jolanta, et al.
Publicado: (2021)

Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP(751)(SL) Mice
por: Lull, Melinda E., et al.
Publicado: (2011)

Whole-body vibration ameliorates glial pathological changes in the hippocampus of hAPP transgenic mice, but does not affect plaque load
por: Oroszi, Tamas, et al.
Publicado: (2023)

Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease
por: Wright, Amanda L., et al.
Publicado: (2013)

Hypertension and Pathogenic hAPP Independently Induce White Matter Astrocytosis and Cognitive Impairment in the Rat
por: Levit, Alexander, et al.
Publicado: (2020)

Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009)

Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice
por: Killick, Richard, et al.
Publicado: (2009)

Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
por: Hendrickx, Jhana O., et al.
Publicado: (2021)

Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease
por: Dhungana, Amolika, et al.
Publicado: (2023)

The Metalloprotease Meprin β Is an Alternative β-Secretase of APP
por: Becker-Pauly, Christoph, et al.
Publicado: (2017)

A Novel hAPP/htau Mouse Model of Alzheimer's Disease: Inclusion of APP With Tau Exacerbates Behavioral Deficits and Zinc Administration Heightens Tangle Pathology
por: Lippi, Stephen L. P., et al.
Publicado: (2018)

Enhanced Cerebral Blood Volume under Normobaric Hyperoxia in the J20-hAPP Mouse Model of Alzheimer’s Disease
por: Shabir, Osman, et al.
Publicado: (2020)

APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
por: Isbert, Simone, et al.
Publicado: (2011)

A Novel 1,4-Dihydropyridine Derivative Improves Spatial Learning and Memory and Modifies Brain Protein Expression in Wild Type and Transgenic APP(SweDI) Mice
por: Jansone, Baiba, et al.
Publicado: (2015)

Phenotypic Differences between the Alzheimer’s Disease-Related hAPP-J20 Model and Heterozygous Zbtb20 Knock-Out Mice
por: Gulbranson, Daniel R., et al.
Publicado: (2021)

Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
por: Bascuñana, Pablo, et al.
Publicado: (2023)

β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014)

Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice
por: Weekman, Erica M, et al.
Publicado: (2014)

Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP
por: Silverberg, Gerald D, et al.
Publicado: (2015)

Thy1-hAPP(Lond/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function
por: Faizi, Mehrdad, et al.
Publicado: (2012)

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
por: Dickey, Chad A, et al.
Publicado: (2005)

Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically
por: Agca, Cansu, et al.
Publicado: (2008)

Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease
por: Zhang, Lan, et al.
Publicado: (2014)

The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice
por: Rijal Upadhaya, Ajeet, et al.
Publicado: (2013)

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
por: Espinoza, Sandra, et al.
Publicado: (2022)

Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice
por: Li, Bin, et al.
Publicado: (2011)

The HAPPE plus Event-Related (HAPPE+ER) software: A standardized preprocessing pipeline for event-related potential analyses
por: Monachino, A.D., et al.
Publicado: (2022)

Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype
por: Whitehouse, Isobel J., et al.
Publicado: (2016)

Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice
por: Luo, Gang, et al.
Publicado: (2016)

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
por: Wilcock, Donna M, et al.
Publicado: (2004)

Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP
por: Wiseman, Frances K, et al.
Publicado: (2018)

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
por: Heneka, Michael T, et al.
Publicado: (2005)

A small molecule targeting protein translation does not rescue spatial learning and memory deficits in the hAPP-J20 mouse model of Alzheimer’s disease
por: Johnson, Erik C.B., et al.
Publicado: (2016)

Estrogen-Dominant Ovarian Cycle Stages Are Associated with Neural Network Dysfunction and Cognitive and Behavioral Deficits in the hAPP-J20 Mouse Model of Alzheimer’s Disease
por: Carney, Rosalind S.E.
Publicado: (2019)

Intravenous Delivery of Targeted Liposomes to Amyloid-β Pathology in APP/PSEN1 Transgenic Mice
por: Tanifum, Eric A., et al.
Publicado: (2012)

The role of APP and BACE1 trafficking in APP processing and amyloid-β generation
por: Zhang, Xiaojie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rs3h4jgq9be8afc54o6itrg9ec